Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...

G-207 is under development for high-grade glioma in children, medulloblastoma, primitive neuroectodermal tumor, ependymoma, atypical teratoid/rhabdoid tumor and germ cell tumor, supratentorial brain ...

G-207 is under development for high-grade glioma in children, medulloblastoma, primitive neuroectodermal tumor, ependymoma, atypical teratoid/rhabdoid tumor and germ cell tumor, supratentorial brain ...

The drug is being developed for various solid tumors, including bladder cancer, head and neck cancer, and glioblastoma ... striking a target (cancer cell) and detonating its warhead (drug).

A recent study found that combined tocilizumab and glucocorticoid therapy for at least 6 months did not fully eliminate ...

Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...

Cecile Richards, a prominent advocate for women's rights and other progressive causes and former President of Planned ...

In addition to the discovery of an early stem cell that could explain the genetics of glioblastoma in adulthood, the data contained hints about the origins of autism. The researchers have published ...

HOLTON, Kan. (WIBW)— Giant Communications announced the launch of Giant Mobile, a new cell phone service that provides affordable and reliable mobile connectivity to customers across Kansas.

The average lifespan of someone diagnosed with the brain tumor is just 12 to 15 months, and only about 5% of people diagnosed with glioblastoma are alive five years after their diagnosis.